|
AVTX | Avalo Therapeutics, Inc. |
|
|
AVTX | Avalo Therapeutics, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.12 |
| Leverage | 8.58% |
| Market Cap | $ 3.8B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -100.2m |
| Margin | 989.58% |
None